Analysts’ Top NA Picks: Rapport Therapeutics, Inc. (RAPP), SpaceX (SPCX)
Analysts reiterated Buy ratings on Rapport Therapeutics (RAPP) with a $82.00 target, SpaceX (SPCX) with a $300.00 target, and Infleqtion (INFQ) with a $25.00 target. RAPP's consensus target is $68.30, SPCX's is $221.03, and INFQ's is $20.67.



